Aimovig can cause side effects ranging from mild to serious. Common side effects include muscle cramps, constipation, and injection site reactions. Severe constipation requiring hospital treatment, ...

Aimovig is a brand-name medication that is prescribed to prevent migraine episodes in adults. It is administered via injection, not for treating symptoms as they occur. Common side effects of Aimovig ...

Aimovig’s (erenumab-aooe) dosage for migraine prevention is typically one 70-milligram (mg) injection per month. Your doctor might increase your dosage to 140 mg per month, depending on your migraine ...

Amgen and Novartis inaugurated a much-anticipated new class of migraine drugs Wednesday with FDA approval for Aimovig, an injectable med laden with blockbuster hopes. But Aimovig has several more ...

Emgality (galcanezumab-gnlm) and Aimovig (erenumab-aooe) are brand-name drugs prescribed to help prevent migraine episodes. Emgality is also prescribed to treat cluster headache. Both drugs are ...

Aimovig is a brand-name prescription medication known as a biologic. Its active ingredient is erenumab-aooe. Generic versions of biologic medications are called biosimilars. Due to complex ...

TRENTON, N.J. (AP) - U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration's action clears the monthly shot Aimovig (AIM'-oh-vig) for ...

Migraine disease is a complex neurological disease affecting an estimated 40 million people in the United States and a billion people worldwide. There are many treatments for migraine, but they’re not ...

The first antibody treatment to prevent migraine (Aimovig), produced by Novartis, is on the cusp of approval. The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP ...

After long-term Aimovig (erenumab) treatment, two-thirds of chronic migraine patients converted to episodic migraine, experiencing 11 fewer migraine days per month on average Separate study showed the ...